HAWK Biosystems Announces strategic Partnership with Axonlab to Enhance Spatial Biology Solutions Across Europe

HAWK Biosystems is proud to announce a strategic partnership with Axonlab, a leader in healthcare solutions known for their proactive and reliable services. This collaboration represents a major advancement in our efforts to bring our cutting-edge QF-Pro® technology to both academic and medical researchers across Europe.

About Axonlab

Axonlab is a cutting-edge, customer-oriented service company operating in the fields of In Vitro Diagnostics (IVD), Life Science, and Medical IT markets. With a strong presence in the point-of-care solutions business in Europe, Axonlab has established itself as a leading company by consistently delivering innovative systems to hospitals, medical practices, private laboratories, research institutions, and private individuals.

For over 30 years, Axonlab has been committed to providing personalised solutions and the highest level of process know-how across the entire service chain. The company collaborates with reputable international supply partners to ensure that clinics, doctors, and researchers have access to the latest advancements in healthcare technology.

Shared Vision and Goals

The partnership between HAWK Biosystems and Axonlab is based on a shared vision of improving healthcare and enhancing the quality of life for patients across Europe by enabling researchers to study protein functional states. Axonlab’s dedication to comprehensive, future-oriented service and building long-term business relations aligns perfectly with HAWK Biosystems’ commitment to innovation and excellence in spatial biology technology.

Benefits of the Partnership

By joining forces with Axonlab, HAWK Biosystems will leverage Axonlab’s extensive distribution network and deep expertise in the healthcare sector. This collaboration will facilitate the introduction of HAWK Biosystems’ state-of-the-art platforms to a broader market, enabling more researchers and healthcare providers to benefit from our highly sensitive and accurate QF-Pro® technology.

Looking Ahead

As we embark on this exciting partnership, both HAWK Biosystems and Axonlab are committed to driving forward the development and deployment of innovative spatial biology solutions. Together, we aim to set new standards in the life science and spatial biology industries, ensuring that patients receive the highest quality of care through improved diagnostic and research capabilities.

For more information about our partnership and how it will benefit the life science and spatial biology sector please contact our customer service team.

Share this post

Skip to content